Drugs that contain Lamotrigine

1. List of Lamictal Odt drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7919115 GLAXOSMITHKLINE LLC Orally disintegrating tablet compositions of lamotrigine
Jan, 2029

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8840925 GLAXOSMITHKLINE LLC Orally disintegrating tablet compositions of lamotrigine
Jul, 2028

(5 years from now)

US9339504 GLAXOSMITHKLINE LLC Orally disintegrating tablet compositions of lamotrigine
Jul, 2028

(5 years from now)

Market Authorisation Date: 08 May, 2009

Treatment: Lamictal is an antiepileptic drug (aed) indicated for: epilepsy-adjunctive therapy in patients greater than or equal to 2 years of age: (1.1) partial seizures primary generalized tonic-clonic seizures

Dosage: TABLET, ORALLY DISINTEGRATING;ORAL

How can I launch a generic of LAMICTAL ODT before it's patent expiration?
More Information on Dosage

LAMICTAL ODT family patents

7

United States

2

Hong Kong

2

China

2

Japan

1

Australia

1

Brazil

1

Chile

1

Canada

1

New Zealand

1

Taiwan

1

Argentina

1

Uruguay

1

European Union

2. List of Lamictal Xr drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9144547 GLAXOSMITHKLINE LLC Oral dosage form for controlled drug release
Sep, 2023

(3 months from now)

US8637512 GLAXOSMITHKLINE LLC Formulations and method of treatment
Jun, 2028

(5 years from now)

Market Authorisation Date: 29 May, 2009

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of LAMICTAL XR before it's patent expiration?
More Information on Dosage

LAMICTAL XR family patents

7

United Kingdom

4

China

4

Japan

4

United States

3

Korea, Republic of

3

European Union

2

Poland

2

Canada

2

Slovenia

2

Brazil

2

Hong Kong

2

Taiwan

2

Iceland

2

Morocco

2

Germany

2

Cyprus

2

Denmark

2

Argentina

2

Spain

2

Mexico

2

New Zealand

2

Australia

2

Colombia

2

Norway

2

South Africa

2

Austria

2

Portugal

2

Russia

2

Israel

2

Malaysia

1

Chile

1

Peru

1

Ukraine

AP

1

AP

1

Uruguay

EA

1

EA

OA

1

OA

1

Ecuador

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in